Potential of digital technology for hypertension management: current status and future prospects

View at publisher
Authors: Takeshi Fujiwara, Kazuomi Kario
Cited by: 2
References: 69

Abstract

INTRODUCTION: Hypertension is a major global health burden and a leading contributor to cardiovascular morbidity and mortality. Recent advances in digital technology - including home blood pressure (BP), telemonitoring, mobile health applications, wearable devices, and clinical decision support systems - have opened new avenues for improving hypertension management by addressing limitations such as clinical inertia, poor medication adherence, and lack of individualized care. These tools support patient engagement, facilitate behavioral change, and enable remote treatment optimization. AREAS COVERED: This review summarizes the current evidence supporting digital interventions for BP control, highlighting findings from recent randomized controlled trials and meta-analyses via PubMed (2000-2025). Evidence indicates that digital strategies have demonstrated significant reductions in systolic BP compared with usual care, with benefits observed across diverse populations and settings. Digital health approaches have also been shown to enhance medication adherence, promote lifestyle modifications, and offer cost-effective alternatives to conventional care. Moreover, their utility during disasters and pandemics underscores their value in ensuring continuity of care. EXPERT OPINION: While challenges remain, including integration into clinical workflows, regulatory considerations, and disparities in access - efforts to validate, standardize, and scale digital solutions will be critical to their successful implementation in routine care.

Fields of Study & Subjects

Blood Pressure and Hypertension Studies Mobile Health and mHealth Applications Telemedicine and Telehealth Implementation

Publication details

Journal / source
Expert Review of Medical Devices
Publisher
Informa UK Limited
Volume
23
Issue
3
Pages
285–294
Publication date
3 February 2026
Language
EN